Skip to content
The Policy VaultThe Policy Vault

LoproxCareFirst (Caremark)

Topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum or other dermatophytes as specified for each product

Preferred products

  • generic topical antifungal agents

Initial criteria

  • The requested drug is NOT being used in a footbath.
  • The patient meets ONE of the following:
  • The patient experienced an inadequate treatment response to a generic topical antifungal agent.
  • The patient experienced an intolerance to a generic topical antifungal agent.
  • The patient has a contraindication that would prohibit a trial of a generic topical antifungal agent.

Approval duration

3 months